AlzeCure’s Abstract on ACD856’s Anti-inflammatory Effects to be Presented at a Leading Alzheimer’s Conference
STOCKHOLM, SWEDEN / ACCESSWIRE / October 1, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...